vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TWIN DISC INC (TWIN). Click either name above to swap in a different company.

TWIN DISC INC is the larger business by last-quarter revenue ($90.2M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). TWIN DISC INC runs the higher net margin — 24.8% vs -38.1%, a 62.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 0.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 10.3%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Twin Disc, Inc. designs, manufactures, and distributes power transmission equipment for a wide range of applications, including marine, off-road vehicle, and industrial. The company was founded in 1918 to manufacture clutches for farm tractors. It is now a worldwide company with subsidiaries or sales offices in Asia, Europe, North America, Oceania, and South America.

PRCT vs TWIN — Head-to-Head

Bigger by revenue
TWIN
TWIN
1.1× larger
TWIN
$90.2M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+19.9% gap
PRCT
20.2%
0.3%
TWIN
Higher net margin
TWIN
TWIN
62.9% more per $
TWIN
24.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
10.3%
TWIN

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
PRCT
PRCT
TWIN
TWIN
Revenue
$83.1M
$90.2M
Net Profit
$-31.6M
$22.4M
Gross Margin
64.9%
24.8%
Operating Margin
-4.1%
2.3%
Net Margin
-38.1%
24.8%
Revenue YoY
20.2%
0.3%
Net Profit YoY
-27.9%
2334.3%
EPS (diluted)
$-0.56
$1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TWIN
TWIN
Q1 26
$83.1M
Q4 25
$76.4M
$90.2M
Q3 25
$83.3M
$80.0M
Q2 25
$79.2M
$96.7M
Q1 25
$69.2M
$81.2M
Q4 24
$68.2M
$89.9M
Q3 24
$58.4M
$72.9M
Q2 24
$53.4M
$84.4M
Net Profit
PRCT
PRCT
TWIN
TWIN
Q1 26
$-31.6M
Q4 25
$-29.8M
$22.4M
Q3 25
$-21.4M
$-518.0K
Q2 25
$-19.6M
$1.4M
Q1 25
$-24.7M
$-1.5M
Q4 24
$-18.9M
$919.0K
Q3 24
$-21.0M
$-2.8M
Q2 24
$-25.6M
$7.4M
Gross Margin
PRCT
PRCT
TWIN
TWIN
Q1 26
64.9%
Q4 25
60.6%
24.8%
Q3 25
64.8%
28.7%
Q2 25
65.4%
31.0%
Q1 25
63.9%
26.7%
Q4 24
64.0%
24.1%
Q3 24
63.2%
26.5%
Q2 24
59.0%
29.7%
Operating Margin
PRCT
PRCT
TWIN
TWIN
Q1 26
-4.1%
Q4 25
-40.6%
2.3%
Q3 25
-27.8%
2.8%
Q2 25
-28.0%
5.5%
Q1 25
-39.7%
2.4%
Q4 24
-28.9%
3.1%
Q3 24
-38.4%
-0.2%
Q2 24
-50.3%
5.6%
Net Margin
PRCT
PRCT
TWIN
TWIN
Q1 26
-38.1%
Q4 25
-39.1%
24.8%
Q3 25
-25.7%
-0.6%
Q2 25
-24.7%
1.5%
Q1 25
-35.8%
-1.8%
Q4 24
-27.6%
1.0%
Q3 24
-35.9%
-3.8%
Q2 24
-48.0%
8.8%
EPS (diluted)
PRCT
PRCT
TWIN
TWIN
Q1 26
$-0.56
Q4 25
$-0.54
$1.55
Q3 25
$-0.38
$-0.04
Q2 25
$-0.35
$0.10
Q1 25
$-0.45
$-0.11
Q4 24
$-0.34
$0.07
Q3 24
$-0.40
$-0.20
Q2 24
$-0.50
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TWIN
TWIN
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
$44.5M
Stockholders' EquityBook value
$347.7M
$184.5M
Total Assets
$487.1M
$384.0M
Debt / EquityLower = less leverage
0.15×
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TWIN
TWIN
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
PRCT
PRCT
TWIN
TWIN
Q1 26
$51.7M
Q4 25
$51.6M
$44.5M
Q3 25
$51.6M
$43.7M
Q2 25
$51.5M
$31.4M
Q1 25
$51.5M
$40.8M
Q4 24
$51.5M
$24.9M
Q3 24
$51.4M
$29.8M
Q2 24
$51.4M
$25.8M
Stockholders' Equity
PRCT
PRCT
TWIN
TWIN
Q1 26
$347.7M
Q4 25
$365.9M
$184.5M
Q3 25
$380.3M
$160.3M
Q2 25
$385.8M
$164.0M
Q1 25
$389.2M
$149.5M
Q4 24
$402.2M
$147.0M
Q3 24
$241.2M
$157.5M
Q2 24
$251.8M
$154.7M
Total Assets
PRCT
PRCT
TWIN
TWIN
Q1 26
$487.1M
Q4 25
$508.1M
$384.0M
Q3 25
$511.5M
$363.5M
Q2 25
$513.1M
$355.6M
Q1 25
$519.4M
$332.9M
Q4 24
$534.0M
$307.4M
Q3 24
$374.1M
$323.5M
Q2 24
$374.4M
$312.1M
Debt / Equity
PRCT
PRCT
TWIN
TWIN
Q1 26
0.15×
Q4 25
0.14×
0.24×
Q3 25
0.14×
0.27×
Q2 25
0.13×
0.19×
Q1 25
0.13×
0.27×
Q4 24
0.13×
0.17×
Q3 24
0.21×
0.19×
Q2 24
0.20×
0.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
TWIN
TWIN
Operating Cash FlowLast quarter
$4.6M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
1.4%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
0.20×
TTM Free Cash FlowTrailing 4 quarters
$-70.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
TWIN
TWIN
Q1 26
Q4 25
$-10.3M
$4.6M
Q3 25
$-6.6M
$-7.5M
Q2 25
$-15.0M
$16.4M
Q1 25
$-17.0M
$3.2M
Q4 24
$-32.4M
$8.7M
Q3 24
$-18.8M
$-4.3M
Q2 24
$-15.7M
$11.4M
Free Cash Flow
PRCT
PRCT
TWIN
TWIN
Q1 26
Q4 25
$-12.2M
$1.2M
Q3 25
$-9.5M
$-11.0M
Q2 25
$-17.8M
$8.7M
Q1 25
$-18.8M
$906.0K
Q4 24
$-33.6M
$5.9M
Q3 24
$-19.0M
$-6.7M
Q2 24
$-16.8M
$10.3M
FCF Margin
PRCT
PRCT
TWIN
TWIN
Q1 26
Q4 25
-15.9%
1.4%
Q3 25
-11.4%
-13.7%
Q2 25
-22.5%
9.0%
Q1 25
-27.2%
1.1%
Q4 24
-49.2%
6.5%
Q3 24
-32.6%
-9.2%
Q2 24
-31.4%
12.2%
Capex Intensity
PRCT
PRCT
TWIN
TWIN
Q1 26
Q4 25
2.4%
3.7%
Q3 25
3.4%
4.3%
Q2 25
3.5%
8.0%
Q1 25
2.7%
2.8%
Q4 24
1.7%
3.1%
Q3 24
0.4%
3.2%
Q2 24
2.0%
1.3%
Cash Conversion
PRCT
PRCT
TWIN
TWIN
Q1 26
Q4 25
0.20×
Q3 25
Q2 25
11.55×
Q1 25
Q4 24
9.42×
Q3 24
Q2 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TWIN
TWIN

Segment breakdown not available.

Related Comparisons